Predicts initial tacrolimus dose based on CYP3A5 genotype (*1 expressers vs *3 non-expressers), kidney vs liver transplant, and race-based metabolizer status to reduce time to therapeutic range.
Predicts initial tacrolimus dose based on CYP3A5 genotype (*1 expressers vs *3 non-expressers), kidney vs liver transplant, and race-based metabolizer status to reduce time to therapeutic range
Each component has a specific meaning:
Note: Interpret the tacrolimus pgx result against the thresholds and context described above.
Enter the CYP3A5 genotype, kidney vs liver transplant, race-based metabolizer status for the scenario you are assessing. Predicts initial tacrolimus dose based on CYP3A5 genotype (*1 expressers vs *3 non-expressers), kidney vs liver transplant, and race-based metabolizer status to reduce time to therapeutic range. Use the tacrolimus pgx result to inform your calculation.